Search Results Search Sort by RelevanceMost Recent Viewpoint Oct 2003 Ethical Considerations with Electroconvulsive Therapy Richard D. Weiner, MD, PhD Virtual Mentor. 2003;5(10):467-469. doi: 10.1001/virtualmentor.2003.5.10.oped2-0310. Case and Commentary Jul 2001 Is It Covered or Not? Health Plans and Experimental Procedures Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(7):224-225. doi: 10.1001/virtualmentor.2001.3.7.hlaw1-0107. Personal Narrative Jul 2001 Through the Physician's Eyes: A First-Year Resident's Obstetrical Ethical Dilemma Vickie Mello, DO Virtual Mentor. 2001;3(7):240-241. doi: 10.1001/virtualmentor.2001.3.7.prsp2-0107. Policy Forum Jul 2015 Comparative Effectiveness Research Would Contribute More to Ethical Policy Making if Cost Were Considered Kevin D. Frick, PhD Using data from comparative effectiveness studies to inform cost-effectiveness analyses or other economic evaluations would strengthen ethical policy making. AMA J Ethics. 2015;17(7):651-655. doi: 10.1001/journalofethics.2015.17.7.pfor1-1507. Viewpoint Aug 2002 A Better Perspective: Dr. Alan Heins and the CATCH Program Susanna Smith Virtual Mentor. 2002;4(8):244-245. doi: 10.1001/virtualmentor.2002.4.8.prol1-0208. Case and Commentary Nov 2001 Commemorative Issue: Is It the Money? and In a Bind? Audiey Kao, MD, PhD Virtual Mentor. 2001;3(11):377-378. doi: 10.1001/virtualmentor.2001.3.11.ccas1-0111. Case and Commentary Jan 2001 Financial Incentives in Managed Care Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(1):3-. doi: 10.1001/virtualmentor.2001.3.1.hlaw1-0101. Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 1 Jim Kirkpatrick, MD Virtual Mentor. 2002;4(6):159-163. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206. Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 2 Erin Egan, MD, JD and Kayhan Parsi, JD, PhD Virtual Mentor. 2002;4(6):164-168. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206. State of the Art and Science Mar 2002 Pharmacogenomics: Revolution in a Bottle? Faith Lagay, PhD Virtual Mentor. 2002;4(3):62-66. doi: 10.1001/virtualmentor.2002.4.3.gnth1-0203. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Viewpoint Oct 2003 Ethical Considerations with Electroconvulsive Therapy Richard D. Weiner, MD, PhD Virtual Mentor. 2003;5(10):467-469. doi: 10.1001/virtualmentor.2003.5.10.oped2-0310.
Case and Commentary Jul 2001 Is It Covered or Not? Health Plans and Experimental Procedures Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(7):224-225. doi: 10.1001/virtualmentor.2001.3.7.hlaw1-0107.
Personal Narrative Jul 2001 Through the Physician's Eyes: A First-Year Resident's Obstetrical Ethical Dilemma Vickie Mello, DO Virtual Mentor. 2001;3(7):240-241. doi: 10.1001/virtualmentor.2001.3.7.prsp2-0107.
Policy Forum Jul 2015 Comparative Effectiveness Research Would Contribute More to Ethical Policy Making if Cost Were Considered Kevin D. Frick, PhD Using data from comparative effectiveness studies to inform cost-effectiveness analyses or other economic evaluations would strengthen ethical policy making. AMA J Ethics. 2015;17(7):651-655. doi: 10.1001/journalofethics.2015.17.7.pfor1-1507.
Viewpoint Aug 2002 A Better Perspective: Dr. Alan Heins and the CATCH Program Susanna Smith Virtual Mentor. 2002;4(8):244-245. doi: 10.1001/virtualmentor.2002.4.8.prol1-0208.
Case and Commentary Nov 2001 Commemorative Issue: Is It the Money? and In a Bind? Audiey Kao, MD, PhD Virtual Mentor. 2001;3(11):377-378. doi: 10.1001/virtualmentor.2001.3.11.ccas1-0111.
Case and Commentary Jan 2001 Financial Incentives in Managed Care Kayhan Parsi, JD, PhD Virtual Mentor. 2001;3(1):3-. doi: 10.1001/virtualmentor.2001.3.1.hlaw1-0101.
Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 1 Jim Kirkpatrick, MD Virtual Mentor. 2002;4(6):159-163. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206.
Case and Commentary Jun 2002 Right to Discontinue Treatment, Commentary 2 Erin Egan, MD, JD and Kayhan Parsi, JD, PhD Virtual Mentor. 2002;4(6):164-168. doi: 10.1001/virtualmentor.2002.4.6.ccas1-0206.
State of the Art and Science Mar 2002 Pharmacogenomics: Revolution in a Bottle? Faith Lagay, PhD Virtual Mentor. 2002;4(3):62-66. doi: 10.1001/virtualmentor.2002.4.3.gnth1-0203.